A PHASE I/II TRIAL OF ADJUVANT 3-D CONFORMAL RADIATION THERAPY, HORMONAL THERAPY, AND CONCURRENT DOCETAXEL FOR HIGH-RISK PATHOLOGIC T2-T3N0M0 PROSTAT
$1,042,338FY2008Department of DefenseDOD
University Of Southern California, Los Angeles CA
University Of Southern California, Los Angeles CA